KVUE Kenvue Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
18:37
Mar 13
Mar 13
CNBC
"Companies that would have exposure to a pressured consumer... risk of margin pressure from logistics costs... Spectrum, Newell Brands, Traeger, Kenvue, Smucker... Reynolds... exposure to the Middle East, like Pepsi, Mondelez, Coke and Procter and Gamble." (Nik Modi confirms: "Every one of my stocks is going to get impacted.") Rising energy and fertilizer costs squeeze consumer wallets while simultaneously increasing corporate logistics and production costs. Because consumer volumes are already lagging, these global packaged food and household goods companies cannot pass these new costs onto the consumer via price hikes, leading directly to margin compression. AVOID global consumer staples and packaged foods with high international logistics exposure, Middle East exposure, or limited pricing power. Energy and fertilizer prices could rapidly stabilize; companies might successfully implement aggressive cost-cutting measures to protect margins; investors may continue to blindly buy these names as a defensive safe haven regardless of fundamentals.
KVUE
Kenvue Inc.
Avoid
—
—
16:39
Feb 03
Feb 03
r/ValueInvesting
Buy KVUE for merger cash plus discounted KMB
Author purchased KVUE shares because the pending KVUE-KMB merger pays KVUE holders 0.14625 KMB shares plus $3.50 cash per share, effectively giving a discounted entry into KMB at roughly $94 plus a cash bonus. The catalyst is completion of the merger, currently pending DOJ approval, and the author views KMB as a mature dividend payer with emerging-market growth that will benefit from the KVUE acquisition. Main stated risk is that the deal is still pending DOJ approval.
KVUE
Kenvue Inc.
Long
1ST
—
—
22:19
Jan 28
Jan 28
r/ValueInvesting
Kenvue undervalued consumer brands; potential Kimberly merger.
The author views Kenvue as an underrated consumer-health company trading at a P/E around 22, comparable to pharma peers, with strong brands like Tylenol, Neutrogena, Listerine and Band-Aid. He argues the brand portfolio and good statistics support value, and a merger with Kimberly would create a consumer-care powerhouse.
KVUE
Kenvue Inc.
Long
1ST
—
—
About KVUE Investor Commentary
Across the available history and selected sources, Buzzberg tracks KVUE (Kenvue Inc.) across 9 sources: 4 bullish vs 0 bearish calls from 13 authors. Historical directional balance: 22% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 18 total trade ideas tracked. Past 7 days, before deduplication: 3 other directions. Latest voices: Kelly Evans, u/ultra__star, u/paranoidspectator.